Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of omadacycline as compared to moxifloxacin in the treatment of adults with community-acquired bacterial pneumonia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02531438
Study type Interventional
Source Paratek Pharmaceuticals Inc
Contact
Status Completed
Phase Phase 3
Start date November 2015
Completion date March 10, 2017

See also
  Status Clinical Trial Phase
Terminated NCT01570192 - Clinical Trials to Reduce the Risk of Antimicrobial Resistance Phase 2
Recruiting NCT04952337 - Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
Completed NCT02493764 - Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) Phase 3
Completed NCT00079885 - Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia Phase 3
Recruiting NCT05629741 - A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 Phase 1
Completed NCT05417997 - Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients Phase 3
Withdrawn NCT00645619 - Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
Completed NCT00509106 - Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia Phase 3
Completed NCT00080496 - Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia Phase 3
Completed NCT03158727 - Cx611-0204 SEPCELL Study Phase 1/Phase 2
Completed NCT00621504 - Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia Phase 3
Completed NCT00124020 - Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Phase 3
Completed NCT00081575 - Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia Phase 3
Completed NCT00451386 - Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036) Phase 2
Recruiting NCT03752320 - Multiplex Polymerase Chain Reaction in Postoperative Pneumonia After Thoracic Surgery
Active, not recruiting NCT04779242 - Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia Phase 3
Completed NCT00763620 - Assessment of the Diagnostic Capacity of the Mini-broncho Alveolar Lavage Performed Through a Suction Catheter N/A
Completed NCT00107952 - Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Phase 3
Terminated NCT03862040 - Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia Phase 1
Recruiting NCT05531149 - Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia Phase 3